← Mechanisms of action
CD3E
SINGLE PROTEINHomo sapiens
Preferred name: T-cell surface glycoprotein CD3 epsilon chain ChEMBL ↗
Linked proteins
Drugs acting on this target (231)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| abbv-184 | Activator | experimental | mAb | CD3E activator |
| abbv-243 | Activator | experimental | mAb | CD3E activator |
| abo2203 | Activator | experimental | mAb | CD3E activator |
| afm11 | Activator | experimental | mAb | CD3E activator |
| alps12 | Activator | experimental | mAb | CD3E activator |
| amg 211 | Activator | experimental | mAb | CD3E activator |
| amg 305 | Activator | experimental | mAb | CD3E activator |
| amg 330 | Activator | experimental | mAb | CD3E activator |
| asp2138 | Activator | experimental | mAb | CD3E activator |
| azd4360 | Activator | experimental | mAb | CD3E activator |
| azd5492 | Activator | experimental | mAb | CD3E activator |
| azd5863 | Activator | experimental | mAb | CD3E activator |
| azd6621 | Activator | experimental | mAb | CD3E activator |
| ba1202 | Activator | experimental | mAb | CD3E activator |
| ba3182 | Activator | experimental | mAb | CD3E activator |
| bcd-248 | Activator | experimental | mAb | CD3E activator |
| bgb-b455 | Activator | experimental | mAb | CD3E activator |
| bi 836909 | Activator | experimental | mAb | CD3E activator |
| bite-ev | Activator | experimental | mAb | CD3E activator |
| blinatumomab (blincyto) | Activator | approved | mAb | CD3E activator |
| bms-986528 | Activator | experimental | mAb | CD3E activator |
| br115 | Activator | experimental | mAb | CD3E activator |
| catumaxomab (Removab) | Activator | experimental | mAb | CD3E activator |
| cba-1535 | Activator | experimental | mAb | CD3E activator |
| cbi-1214 | Activator | experimental | mAb | CD3E activator |
| cc312 | Activator | experimental | mAb | CD3E activator |
| cdr404 | Activator | experimental | mAb | CD3E activator |
| cln-978 | Activator | experimental | mAb | CD3E activator |
| clsp-1025 | Activator | experimental | mAb | CD3E activator |
| cm-336 | Activator | experimental | mAb | CD3E activator |
| cm336 | Activator | experimental | mAb | CD3E activator |
| CM350 | Activator | experimental | mAb | CD3E |
| cnd261 | Activator | experimental | mAb | CD3E activator |
| ctim-76 | Activator | experimental | mAb | CD3E activator |
| duvortuxizumab | Activator | experimental | mAb | CD3E activator |
| Elranatamab (Elrexfio) | Activator | approved | mAb | CD3E activator |
| Epcoritamab (Epkinly) | Activator | approved | mAb | CD3E activator |
| ertumaxomab | Activator | experimental | mAb | CD3E activator |
| ery974 | Activator | experimental | mAb | CD3E activator |
| ex103 | Activator | experimental | mAb | CD3E activator |
| f182112 | Activator | experimental | mAb | CD3E activator |
| fbta05 | Activator | experimental | mAb | CD3E activator |
| Flotetuzumab | Activator | experimental | mAb | CD3E activator |
| gb261 | Activator | experimental | mAb | CD3E activator |
| gbr 1302 | Activator | experimental | mAb | CD3E activator |
| gen3017 | Activator | experimental | mAb | CD3E activator |
| glofitamab (Columvi) | Activator | approved | mAb | CD3E activator |
| gnc-077 | Activator | experimental | mAb | CD3E activator |
| gprc5d/cd3 bites | Activator | experimental | mAb | CD3E activator |
| gr1803 | Activator | experimental | mAb | CD3E activator |
| gsk5458514 | Activator | experimental | mAb | CD3E activator |
| hy05350 | Activator | experimental | mAb | CD3E activator |
| igm-2644 | Activator | experimental | mAb | CD3E activator |
| imc-p115c | Activator | experimental | mAb | CD3E activator |
| imc-r117c | Activator | experimental | mAb | CD3E activator |
| inca036873 | Activator | experimental | mAb | CD3E activator |
| isb 2001 | Activator | experimental | mAb | CD3E activator |
| janx007 | Activator | experimental | mAb | CD3E activator |
| jnj-63709178 | Activator | experimental | mAb | CD3E activator |
| jnj-75348780 | Activator | experimental | mAb | CD3E activator |
| jnj-79635322 | Activator | experimental | mAb | CD3E activator |
| jnj-80948543 | Activator | experimental | mAb | CD3E activator |
| jnj-87801493 | Activator | experimental | mAb | CD3E activator |
| jnj-87890387 | Activator | experimental | mAb | CD3E activator |
| js203 | Activator | experimental | mAb | CD3E activator |
| lava-1207 | Activator | experimental | mAb | CD3E activator |
| lbl-033 | Activator | experimental | mAb | CD3E activator |
| lnf2007 | Activator | experimental | mAb | CD3E activator |
| lp-001 | Activator | experimental | mAb | CD3E activator |
| ly4152199 | Activator | experimental | mAb | CD3E activator |
| mbs303 | Activator | experimental | mAb | CD3E activator |
| mbs314 | Activator | experimental | mAb | CD3E activator |
| mcla-117 | Activator | experimental | mAb | CD3E activator |
| mdx2001 | Activator | experimental | mAb | CD3E activator |
| mdx2003 | Activator | experimental | mAb | CD3E activator |
| mdx2004 | Activator | experimental | mAb | CD3E activator |
| medi-565 | Activator | experimental | mAb | CD3E activator |
| mgd007 | Activator | experimental | mAb | CD3E activator |
| mgd009 | Activator | experimental | mAb | CD3E activator |
| mor209 | Activator | experimental | mAb | CD3E |
| msc303 | Activator | experimental | mAb | CD3E activator |
| mt110 | Activator | experimental | mAb | CD3E activator |
| muromonab cd3 (Orthoclone OKT3) | Activator | approved | mAb | CD3E activator |
| ni-0401 | Activator | experimental | mAb | CD3E activator |
| nilk-2301 | Activator | experimental | mAb | CD3E activator |
| nm32-2668 | Activator | experimental | mAb | CD3E activator |
| om336 | Activator | experimental | mAb | CD3E activator |
| pit565 | Activator | experimental | Small molecule | CD3E activator |
| qls7305 | Activator | experimental | mAb | CD3E activator |
| resimmune | Activator | experimental | mAb | CD3E activator |
| ro7444973 | Activator | experimental | Recombinant protein | CD3E activator |
| ro7617991 | Activator | experimental | mAb | CD3E activator |
| sctb35 | Activator | experimental | mAb | CD3E activator |
| sim0500 | Activator | experimental | mAb | CD3E activator |
| smet12 | Activator | experimental | mAb | CD3E activator |
| soa101 | Activator | experimental | mAb | CD3E activator |
| star0602 | Activator | experimental | Recombinant protein | CD3E activator |
| tak-280 | Activator | experimental | mAb | CD3E activator |
| Talquetamab (Talvey) | Activator | approved | mAb | CD3E activator |
| tgi-6 | Activator | experimental | mAb | CD3E activator |
| tqb2029 | Activator | experimental | mAb | CD3E activator |
| vnx-101 | Activator | experimental | Gene therapy | CD3E activator |
| vnx-202 | Activator | experimental | mAb | CD3E activator |
| wvt078 | Activator | experimental | Cell therapy | CD3E activator |
| xmab541 | Activator | experimental | mAb | CD3E activator |
| yk012 | Activator | experimental | mAb | CD3E activator |
| ykst02 | Activator | experimental | mAb | CD3E activator |
| zw171 | Activator | experimental | mAb | CD3E activator |
| ro7616789 | Adcc | experimental | mAb | CD3E adcc |
| A-337 | Agonist | experimental | mAb | CD3E agonist |
| abbv-383 | Agonist | experimental | mAb | CD3E |
| AMG-910 | Agonist | experimental | mAb | CD3E |
| arb202 | Agonist | experimental | mAb | cd3e |
| bay2010112 | Agonist | experimental | mAb | CD3E |
| bi 765049 | Agonist | experimental | mAb | CD3E |
| BIS-1 | Agonist | experimental | mAb | CD3E |
| btrc4017a | Agonist | experimental | mAb | CD3E |
| cc-1 | Agonist | experimental | mAb | CD3E agonist |
| cc-3 | Agonist | experimental | mAb | CD3E agonist |
| cd33*cd3 bsab | Agonist | experimental | mAb | CD3E |
| cln-049 | Agonist | experimental | mAb | CD3E |
| cm355 | Agonist | experimental | mAb | CD3E |
| cx-904 | Agonist | experimental | mAb | CD3E |
| emb-06 | Agonist | experimental | mAb | CD3E |
| emb07 | Agonist | experimental | mAb | CD3E |
| fbta05 | Agonist | experimental | mAb | CD3E |
| gen1047 | Agonist | experimental | mAb | CD3E |
| gnc-035 | Agonist | experimental | mAb | CD3E |
| gnc-038 | Agonist | experimental | mAb | CD3E agonist |
| gnc-039 | Agonist | experimental | mAb | CD3E |
| hegfrviii-cd3 | Agonist | experimental | mAb | CD3E |
| ima401 | Agonist | experimental | mAb | CD3E agonist |
| jnj-78278343 | Agonist | experimental | mAb | CD3E |
| jnj-78306358 | Agonist | experimental | mAb | CD3E |
| mgd020 | Agonist | experimental | mAb | CD3e |
| mgd024 | Agonist | experimental | mAb | CD3E |
| mor209 | Agonist | experimental | mAb | CD3E |
| mosunetuzumab (Lunsumio) | Agonist | approved | mAb | CD3E agonist |
| MVC-101 | Agonist | experimental | mAb | CD3E |
| nivatrotamab | Agonist | experimental | mAb | CD3E agonist |
| NVG-111 | Agonist | experimental | mAb | CD3E |
| oc-tr | Agonist | experimental | mAb | CD3E |
| pf-07260437 | Agonist | experimental | mAb | CD3E |
| qls31904 | Agonist | experimental | mAb | CD3e |
| qls31905 | Agonist | experimental | mAb | cd3e |
| regn4336 | Agonist | experimental | mAb | CD3E |
| rg 6007 | Agonist | experimental | mAb | CD3E |
| sar442257 | Agonist | experimental | mAb | CD3E |
| sar443216 | Agonist | experimental | mAb | CD3E |
| shr1 | Agonist | experimental | mAb | CD3E |
| TNB-486 | Agonist | experimental | mAb | CD3E |
| TNB-585 | Agonist | experimental | mAb | CD3E |
| tqb2825 | Agonist | experimental | mAb | CD3E agonist |
| tqb2934 | Agonist | experimental | mAb | CD3E agonist |
| XMab-15426 | Agonist | experimental | mAb | CD3E |
| xmab13676 | Agonist | experimental | mAb | CD3E |
| xmab18968 | Agonist | experimental | mAb | CD3E |
| xmab819 | Agonist | experimental | mAb | cd3e |
| y150 | Agonist | experimental | mAb | CD3E |
| otelixizumab | Binding agent | experimental | mAb | CD3E binding agent |
| resimmune | Binding agent | experimental | mAb | T-cell surface glycoprotein CD3 epsilon chain binding agent |
| teclistamab (Tecvayli) | Chelating agent | approved | mAb | CD3E chelating agent |
| catumaxomab (Removab) | Cross-linking agent | experimental | mAb | CD3E cross-linking agent |
| ertumaxomab | Cross-linking agent | experimental | mAb | T-cell surface glycoprotein CD3 epsilon chain cross-linking agent |
| medi-565 | Cross-linking agent | experimental | mAb | CD3E cross-linking agent |
| amg 160 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| amg 171 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| amg 199 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| amg 420 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| amg 424 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| amg 427 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| amg 509 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| amg 562 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| amg 673 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| amg 701 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| amg 910 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| amv564 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| anti-cd3 conjugated to recombinant ricin a chain | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| anti-cd3-muc1 bispecific antibody | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| bi 764532 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| btrc4017a | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| cc-93269 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| cc-95266 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| cc-99712 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| cd20-tcb | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| cibisatamab | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| foralumab | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| gbr 1342 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| gem333 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| gem3psca | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| gen1044 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| gnr-084 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| hpn328 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| hpn424 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| hpn536 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| igm-2323 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| imc-c103c | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| jnj-63898081 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| jnj-67571244 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| linvoseltamab (Lynozyfic) | Immunity, passive | approved | mAb | CD3E immunity, passive |
| m701 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| m802 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| ono-4685 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| otelixizumab | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| pf-06671008 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| pf-07062119 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| psmaxcd3 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| regn1979 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| regn4018 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| regn5459 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| ro6895882 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| ro7293583 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| sar440234 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| sl-172154 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| tarlatamab (IMDELLTRA) | Immunity, passive | approved | mAb | CD3E immunity, passive |
| teplizumab (Tzield) | Immunity, passive | approved | mAb | CD3E immunity, passive |
| tnb-383b | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| visilizumab | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| xmab13676 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| xmab14045 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| xmab18087 | Immunity, passive | experimental | mAb | CD3E immunity, passive |
| A-319 | Inhibitor | experimental | mAb | CD3E inhibitor |
| amx 818 | Inhibitor | experimental | Recombinant protein | CD3E inhibitor |
| apvo436 | Inhibitor | experimental | mAb | CD3E inhibitor |
| bfcr4350a | Inhibitor | experimental | mAb | CD3E inhibitor |
| isb 1302 | Inhibitor | experimental | mAb | CD3E inhibitor |
| mgd014 | Inhibitor | experimental | mAb | CD3E inhibitor |
| muromonab cd3 (Orthoclone OKT3) | Inhibitor | approved | mAb | CD3E inhibitor |
| regn7041 | Inhibitor | experimental | mAb | CD3E inhibitor |
| visilizumab | Inhibitor | experimental | mAb | CD3E inhibitor |
| teplizumab (Tzield) | Other | approved | mAb | CD3E other |